C

CAI

Operational readiness consulting for pharma

Validation Engineer

Full-Time
₹400.1k - ₹17.2M/yr
Senior
Bachelor's, Master's
India
HybridHybrid role; location is India. No further geographic restrictions specified.
Manufacturing Quality & TestValidation, Compliance & Quality Systems

About the job

Requirements
  • A bachelor’s degree or master’s degree in chemical engineering, Biotech Engineering, Mechanical Engineering, Chemistry or Life Sciences, in the Pharmaceutical/Life Sciences industry.
  • Engineering Consultancy (for Biopharma).
  • Led end-to-end CQV and CSV lifecycle activities, including URS, risk assessments, IQ/OQ/PQ execution, and final reporting for GMP-regulated environments.
  • Executed risk-based validation strategies compliant with FDA 21 CFR Part 11, EU Annex 11, and GAMP 5.
  • Managed commissioning of Plant Utilities, Commissioning and qualification of clean utilities, process equipment, HVAC systems, Automation and computerized systems for Biotech API and Fill Finish facilities.
  • Experienced in commissioning, qualification, and validation of Water Systems (PW/WFI), CIP/SIP systems, autoclaves, bioreactors, nitrogen and process air systems.
  • Demonstrated knowledge of upstream and downstream manufacturing equipment qualification, supporting GMP-compliant project execution throughout the equipment and utility lifecycle.
  • Developed and reviewed validation documentation including VMPs, SOPs, RTMs, protocols, and summary reports.
  • Performed FAT, SAT, commissioning, and shakedown testing ensuring seamless transition into qualification phases.
  • Utilized platforms like Kneat / Veeva / TrackWise for electronic validation lifecycle management.
  • Conducted GxP impact assessments, data integrity risk assessments, and FMEA analyses to define validation scope.
  • Collaborated cross-functionally with QA, Engineering, IT, and Vendors to deliver projects on schedule.
  • Managed deviations, CAPA, and change controls ensuring audit-ready documentation at all stages.
  • Mentored junior engineers on CQV/CSV best practices and regulatory expectations.
  • Deviation handling
  • IQ/OQ/PQ execution
  • Audit findings and responses
  • Knowledge on Regulatory frameworks (FDA, ICH, EU, MHRA, GAMP 5, ISPE, ASME BPE)
Responsibilities
  • Develop and execute CQV/CSV validation strategies
  • Prepare and review IQ, OQ, PQ protocols and reports
  • Perform risk assessments (FMEA, GxP, data integrity)
  • Support design reviews, FAT/SAT, commissioning activities
  • Collaborate with Project, QA, Engineering, Manufacturing, IT, System Vendors
  • Maintain audit-ready documentation
  • Use tools like Kneat, Veeva, TrackWise
  • Ensure compliance with: 1. FDA 21 CFR Part 11 2. EU Annex 11 3. ICH Q8/Q9/Q10 4. GAMP 5 5. ISPE Guideline
  • Lead/mentor junior team members
  • Manage timelines, stakeholders, and project execution

About the company

CAI Technical Consulting Malaysia SDN (cagents.com) delivers operational readiness consulting for pharmaceutical, biotechnology, and healthcare clients to prepare for full-scale production. It works by conducting operational readiness assessments and then providing tailored implementation plans that cover project planning, production operations, asset management, reliability, and sustainability, plus specialized services like Digital Pathology Validation for Leica Biosystems. The firm differentiates itself through active industry collaboration, ongoing professional development, and a global, hands-on approach that pairs quick assessments with practical, cost-effective solutions. Its goal is to help clients achieve operational excellence and successful scale-up by delivering ready-to-deploy strategies and compliant processes.

Company Size

1,001-5,000

Company Stage

Pre-seed

Total Funding

$3.4M

Headquarters

Indianapolis, Indiana

Founded

1996

Get referred to CAI

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CAI closed its JLL recapitalization on July 1, 2026, funding acquisitions and technology.
  • CAI expanded Australia hiring in Melbourne and Brisbane during 2026.
  • CAI grew past 850 employees worldwide, signaling sustained demand for CQV services.

What critics are saying

  • JLL Partners owns CAI after July 1, 2026 recapitalization, forcing exit pressure.
  • CAI depends on regulated-industry capital spending; project delays hit utilization fast.
  • Integrated rivals like Jacobs and Thermo Fisher target the same validation and readiness work.

What makes CAI unique

  • CAI specializes in CQV for FDA-regulated and mission-critical facilities since 1996.
  • CAI spans life sciences, data centers, and process manufacturing across North America, Europe, Australia, Asia.
  • CAI pairs consulting with turnkey partnerships like Fedegari for sterilization implementation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • 100% Employee Owned
  • 24 Days PTO/5 Sick days per year + Additional Holidays depending on Country
  • Medical / Dental / Vision (In accordance with each countries’ applicable regulations)
  • Professional Development (Approximately $5,000 paid career-related, continuing education)
  • ESOP/401k – 15% Company Contribution
  • Company Paid Long-Term Disability
  • Company Paid Life Insurance
  • Company Paid Parental Leave (In accordance with each countries’ applicable regulations)
  • Other Benefits Depending on Country

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

4%
Holladay Journal
Sep 22nd, 2026
SMT Energy secures $268M equity partnership with Climate Adaptive Infrastructure for US battery storage expansion

SMT Energy, a developer and operator of battery energy storage systems, has announced an equity partnership with Climate Adaptive Infrastructure (CAI) worth up to $268 million. This follows $32 million previously deployed by CAI into SMT assets. The investment will fund development, construction and operation of battery storage projects across the United States. Combined with tax equity and project-level debt, the capital is expected to enable infrastructure development with aggregate value significantly exceeding the equity provided. SMT's portfolio includes distributed-generation battery storage, utility-scale projects and powered land developments aimed at strengthening grid reliability. CAI's investment aligns with its strategy of supporting scalable infrastructure platforms addressing demand for resilient, lower-carbon energy solutions. Expedition Infrastructure Partners advised SMT Energy on the transaction, with Stoel Rives providing legal counsel. Orrick served as legal counsel to CAI.

PR Newswire
May 5th, 2026
JLL Partners backs CAI to expand life sciences and mission-critical services globally

CAI, a professional services firm specialising in operational readiness for life sciences and mission-critical environments, has agreed to a partnership with New York-based private equity firm JLL Partners to support its next growth phase. The investment will enable CAI to expand its global presence, invest in advanced technologies and enhance its service offerings. The company, which has operated for over 30 years, employs more than 700 professionals across North America, Europe, Australia and Asia. JLL Partners managing director Vikas Mouli cited CAI's reputation for launching cutting-edge facilities with precision and reliability. The transaction has signed definitive documentation but has not yet closed, pending regulatory approvals. CAI specialises in commissioning, qualification and validation services for highly regulated environments, helping organisations deploy complex facilities, systems and technologies.

PR Newswire
May 5th, 2026
CAI Launches Next Chapter with Investment from JLL Partners

/PRNewswire/ -- CAI, a professional services firm dedicated to accelerating operational readiness and excellence in life sciences and mission-critical...

Business Wire
May 22nd, 2024
Cai And Fedegari Group Forge Strategic Partnership To Deliver Transformational Turnkey Sterilization Solutions To Pharmaceutical Manufacturers

INDIANAPOLIS--(BUSINESS WIRE)--CAI, a global company that provides technical, operational consulting, and project management services, today announced its strategic partnership with Fedegari Group, a manufacturer and service provider of high-performance sterilization systems. This partnership will elevate steam sterilization capabilities for companies spanning the life sciences and biotech industries. The goal of the partnership is to improve the application of steam sterilization science and minimize sterilization process implementation time, in order to reduce lifecycle costs, lower cost of goods, as well as streamline manufacturing processes. According to the terms of the partnership, Fedegari and CAI will integrate their offerings to provide a seamless experience from procurement to operation. In addition, the partners will cooperate on developing and validating state-of-the-art sterilization technology, driving science-based sterilization process and protecting both sensitive products and process equipment. "Fedegari is a world leader in providing aseptic manufacturing solutions, without operator intervention to produce advanced sterile products

PR Newswire
Jul 10th, 2023
Impact Of Training On Operational Readiness, Upcoming Webinar Hosted B

Xtalks Life Science Webinars. . His wide-ranging expertise and experience will be integral to the discussion, particularly regarding the development and implementation of successful training programs